RxDoctor Payments Data

Urvi Gonzales, MD

Dermatology · Washington, DCNPI 1114053451

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.3% of the total across 183 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,405 and has fallen 78.2% since, to $306 in 2025. That places this record below the midpoint for dermatology clinicians in DC, where the typical reported total is $3,159.

$4,049in general payments, 2019–2025

Across 183 payments — averaging $22.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$489
  • AbbVie$486
  • E.r. Squibb & Sons, L.L.C.$342
  • Galderma Laboratories, L.p.$286
  • Pfizer$246
  • Incyte Corporation$240
  • plus $2K from 23 others

What the payments were for

  • Food & beverage$4,02199%
  • Education$281%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,049 in reported general payments places this provider in the 50th percentile of 73 dermatology providers in District of Columbia.

See all dermatology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$191,576
Medicare patients
490
Services billed
2,420

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate48$2,422
Desonide22$1,159
Doxycycline Hyclate29$625
Gentamicin Sulfate11$483
Triamcinolone Acetonide48$471
ValacyclovirValacyclovir Hcl16$288
Econazole Nitrate15$273
Ketoconazole25$229
Minoxidil28$192
Nystatin12$192
Mupirocin11$100
Fluconazole13$86

Paid to pharmacies, not to this prescriber.

Other dermatology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →